Christopher Collins

Christopher Collins

Associate

Christopher (CJ) Collins is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth, as well as with venture capital funds and private equity firms. His practice focuses on corporate and securities law, including general corporate representation, financings, mergers and acquisitions, and public offerings.

CJ is admitted in California. He is not admitted in Washington, D.C.

Experience

CJ is admitted in California. He is not admitted in Washington, D.C.

Education

J.D., University of Virginia School of Law, 2022
B.S., Integrated Science and Technology, James Madison University, 2018

Admissions

State Bar of California
Not admitted in the District of Columbia

Credentials

Education

J.D., University of Virginia School of Law, 2022
B.S., Integrated Science and Technology, James Madison University, 2018

Admissions

State Bar of California
Not admitted in the District of Columbia

Recent Insights

Client Highlights

On January 2, 2024, ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity investment in the company by Oberland Capital, with $210 million of gross proceeds received at closing on December 29, 2023. The additional capital provides significant financial resources for ImmunityBio to accelerate its commercialization efforts in anticipation of a potential regulatory approval, as well as to expand its pipeline within the broader urological cancer space. The proceeds will also be used to fund ongoing business operations and clinical trials expanding N-803 (Anktiva®) indications into multiple solid tumors. Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction.

Learn More